Poster Session: Poster Session 3
Monday May 06, 2019 from 17:00 to 18:00
Exhibit-Poster Area

Refreshments will be served


Session Supported by

Poster Discussants
  • P.300 Malignancy incidence after pediatric kidney transplantation: A single-center experience over the past three decades in Japan
    Dr. Yujiro Aoki, Japan
  • P.301 Oxalate retinopathy is irreversible despite early combined liver-kidney transplantation in primary hyperoxaluria type 1
    Dr. Florian Brinkert, Germany
  • P.302 Long-term outcome after pediatric combined liver and kidney transplantation: A CERTAIN registry analysis
    Dr. Florian Brinkert, Germany
  • P.303 Ureterostomy may be a superior alternative to ileal conduits in pediatric kidney transplantation
    Dr. Aleah L Brubaker, United States
  • P.304 Cholangitis following renal transplantation in children with fibrocystic liver disease - a single centre experience
    Dr. Manu Chhabra, Singapore
  • P.305 A Case of the Acute Shoshin Beriberi Syndrome in a Pediatric Post-Transplant Patient with Rapid Recovery after Thiamine Administration
    Dr. Isaac Elias, Canada
  • P.306 Unexpected genetic background of early de - novo tacrolimus-related allograft TMA in children after renal transplantation
    Prof. Ryszard Grenda, Poland
  • P.307 The issues encountered with posterior urethral valves post renal transplant
    Dr. Tholang S Khumalo, South Africa
  • P.308 Comparison of paediatric renal allograft survival and biopsy outcomes between patients with an underlying urological or non-urological diagnosis: A single centre retrospective analysis
    Dr. Ji Soo Kim, United Kingdom
  • P.309 Cardiac complications in a kidney-only transplant recipient with methylmalonic acidaemia
    Dr. Ji Soo Kim, United Kingdom
  • P.310 Barriers to kidney transplantation in children – a prospective national study
    Dr. Matko Marlais, United Kingdom
  • P.311 Incidence of viral infections in children after renal transplantation in Bulgaria
    Dr. Polina Choumnalieva, Bulgaria
  • P.312 Implementation of a Longitudinal Comprehensive Multidisciplinary Transition Program and Seminar – Safely Making the Long Leap to the Adult World
    Dr. Mary Moss Chandran, United States
  • P.313 The influence of vitamin D3 treatment on the risk of development of acute rejection, epithelial-mesenchymal transition (EMT), and interstitial fibrosis among pediatric renal transplant patients
    Prof. B. Handan Ozdemir, Turkey
  • P.314 Targeted Next-Generation Sequencing (NGS) - an useful tool in pre-transplantation work up even in resource constrained set ups
    Prof. Rajiv Sinha, India
  • P.315 Paediatric kidney transplantation into dysfunctional lower urinary tract: A single center experience from Eastern India
    Prof. Rajiv Sinha, India
  • P.316 Leflunomide use in BK virus nephropathy following pediatric kidney transplantation
    Dr. Douglas J Stewart, Canada
  • P.317 Kidney transplant in atypical HUS during Eculizumab Era. A single Center experience
    Dr. Sara Testa, Italy
  • P.319 Overweight and obesity prevalence in children after the transplant. Short and medium-term evolution
    Dr. Jenny Maribel Velasco, Argentina
  • P.320 Surveillance Biopsies in children with Kidney Transplant. Analysis of histological lesions and other implications at 1 year after transplantation. Preliminary experience
    Dr. Jenny Maribel Velasco, Argentina
  • P.321 How common is Lower urinary tract dysfunction (LUTD) in paediatric patients requiring kidney transplant?
    Mrs. Grainne Walsh, United Kingdom
  • P.322 Changes in body composition after renal transplant in children
    Dr. Mara Medeiros, Mexico
  • P.323 Surgical complications after pediatric kidney transplantation
    Dr. Aydin Akdur, Turkey
  • P.330 Multiple gastrointestinal perforations after liver transplantation: A case report
    Dr. Aydin Akdur, Turkey
  • P.331 Should Pediatric Livers be Declined Based on High Donor Transaminases?
    Dr. Amal Aqul, United States
  • P.332 Implementation of a nurse led transplant specialty care team in a Pediatric Intensive Care Unit improves patient safety
    Dr. Mihaela A Damian, United States
  • P.333 Ultrasound-guided percutaneous liver biopsy is a safe procedure in children: a retrospective review of practice at Starship Child Health
    Dr. Kimberley J Brook, New Zealand
  • P.334 Paediatric combined liver-kidney transplantation for primary hyperoxaluria type 1. Should we consider “liver first”?
    Dr. Davide Cussa, Italy
  • P.335 Liver transplantation for acute liver failure in neonatal enteroviral sepsis
    Carmen A Mandac, United States
  • P.336 Pediatric Liver Transplantation: Our Experiences in a Clinical Unit
    Dr. Roxana Martinitto, Argentina
  • P.337 Case report: how the use of embolization avoided a liver transplant
    Mr. Javier Serradilla, Spain
  • P.338 Massive portal venous gas detected by ultrasound of a pediatric patient after liver transplantation
    Prof. Nihal Uslu, Turkey
  • P.339 Perioperative Characteristics and Management of Liver Transplantation for Isolated Methylmalonic Acidemia——The Largest Experience in China
    Dr. Yi-zhou Jiang, People's Republic of China
  • P.340 Dextroplantation of left liver graft in infants
    Prof. Nam-Joon Yi, Korea
  • P.341 Liver Transplantation for Neonatal Alloimmune Hepatitis
    Dr. Ivone Malla, Argentina
  • P.345 Creation of a family-centered transplant clinic discharge tool
    Ms. Jessie Ahuja, Canada
  • P.346 Grateful Hearts Family Day
    Ms. Susan Blensdorf, United States
  • P.347 An interdisciplinary transplant transition clinic: lessons learned and future directions
    Mrs. Dawn Freiberger, United States
  • P.348 Development of a parent reference guide for percutaneous transhepatic cholangiography with biliary drain placement in pediatric liver transplant recipients
    Mrs. Beverly Kosmach-Park, United States
  • P.349 Obtaining department-wide competency in transplant documentation through development and implementation of guidelines and an online testing module in a large pediatric transplant center
    Miss Jessica B Leonard, United States
  • P.350 A description of serum trace mineral (selenium, copper, and zinc) monitoring within the BC Children’s Hospital Multi-Organ Transplant Program
    Soleina Maherali, Canada
  • P.351 Quality of life in pediatric solid organ transplant: A preliminary descriptive analysis
    Dr. Erin C Moon, Canada
  • P.352 Physical activity of children and adolescents after kidney transplant
    Ms. Kerry West, Australia
  • P.353 Multidisciplinary management of cognitively challenging patients across the transplant journey: a case example
    Mrs. Angela Williams, Canada
  • P.360 Evaluation of micophenolic acid phamacokinetics and its interaction with omeprazol
    Prof. Jose Antonio Mancillas Quiroz, Mexico
  • P.361 Donor specific antibodies and antibody mediated rejection within the 1st year post transplant in pediatric heart transplant recipients is associated with delay in achieving therapeutic tacrolimus levels
    Mrs. Ali L Burnette, United States
  • P.362 The successful use of rectal administration of tacrolimus in a pediatric liver transplant patient.
    Miss Julie A Depper, United States
  • P.363 Association of intraindividual tacrolimus variability with the development of de novo donor-specific HLA antibodies
    Dr. Alexander Fichtner, Germany
  • P.364 Tacrolimus time below therapeutic range and pediatric kidney transplant graft outcomes
    Katie Haubrich, Canada
  • P.365 Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: evolution, risk factors and impact on patient outcomes
    Dr. Agnieszka Prytula, Belgium
  • P.366 Early success in transitioning adolescent kidney transplant recipients to extended-release tacrolimus
    Dr. Alexander H Toledo, United States
  • P.367 A case of post-renal transplant sirolimus-induced colitis in a pediatric patient with cystinosis
    Katherine Twombley, United States
  • P.368 Hemoglobin and Cholesterol Affect Apparent Tacrolimus Clearance in Pediatric Transplant Recipients – a Retrospective Cohort Study
    Miss Elisa C Yoo, Canada
  • P.370 Identification of factors affecting tacrolimus disposition in pediatric liver transplant patients
    Dr. Esteban T Halac, Argentina
  • P.371 Delayed use of rabbit antithymocyte globulin and rituximab in pediatric liver transplantation - a single center 10-year experience
    Dr. Isaac Clouse, United States
  • P.375 Deceased directed donation: Examining the ethics in a multi-cultural setting
    Dr. Rebecca Greenberg, Canada
  • P.376 Diabetic ketoacidosis and hyperosmolar hyperglycemic state in pediatric post-transplant diabetes mellitus
    Dr. Brooke Anderson, United States

© 2021 IPTA 2019